Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
Mitochondrial fatty acid oxidation (FAO) and respiratory chain (RC) defects form a large group of inherited monogenic disorders sharing many common clinical and pathophysiological features, including disruption of mitochondrial bioenergetics, but also, for example, oxidative stress and accumulation...
Main Authors: | Fatima Djouadi, Jean Bastin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/4/289 |
Similar Items
-
KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts
by: Kang-Sik Seo, et al.
Published: (2018-07-01) -
Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells
by: Yang L, et al.
Published: (2020-02-01) -
PPARs: Potential Mechanisms Regulating Blood Lipid and Lipoprotein Concentrations at Rest and Following Exercise in the Obese
by: Greene, Nicholas Perry
Published: (2011) -
Silibinin Restores NAD+ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
by: Federico Salomone, et al.
Published: (2017-09-01) -
Role of PGC-1α in the Mitochondrial NAD<sup>+</sup> Pool in Metabolic Diseases
by: Jin-Ho Koh, et al.
Published: (2021-04-01)